LOAN AGREEMENTLoan Agreement • August 25th, 2023 • Celularity Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 25th, 2023 Company Industry JurisdictionThis Loan Agreement, dated as of August 21, 2023 (“Agreement”), is among Celularity Inc., a Delaware corporation (the “Borrower”), and the lenders party hereto (collectively, the “Lenders” and each, a “Lender” and, together with the Borrower, the “Parties” and each, a “Party”).
AMENDED AND RESTATED LOAN agreementLoan Agreement • June 21st, 2023 • Celularity Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJune 21st, 2023 Company Industry JurisdictionThis Amended and Restated Loan Agreement, dated as of June 20, 2023 (this “Agreement”), is between Celularity Inc., a Delaware corporation (the “Borrower”), and Resorts World Inc Pte Ltd, a company incorporated in Singapore (the “Lender” and, together with the Borrower, the “Parties” and each, a “Party”).
LOAN agreementLoan Agreement • May 16th, 2023 • Celularity Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 16th, 2023 Company Industry JurisdictionThis Loan Agreement, dated as of May 16, 2023 (this “Agreement”), is between Celularity Inc., a Delaware corporation (the “Borrower”), and Resorts World Inc Pte Ltd, a company incorporated in Singapore (the “Lender” and, together with the Borrower, the “Parties” and each, a “Party”).
LOAN agreementLoan Agreement • March 23rd, 2023 • Celularity Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 23rd, 2023 Company Industry JurisdictionThis Loan Agreement, dated as of March 17, 2023 (this “Agreement”), is among Celularity Inc., a Delaware corporation (the “Borrower”), and C.V. Starr & Co. Inc. (the “Lender” and, together with the Borrower, the “Parties” and each, a “Party”).
LOAN agreementLoan Agreement • June 22nd, 2021 • GX Acquisition Corp. • Pharmaceutical preparations • New York
Contract Type FiledJune 22nd, 2021 Company Industry JurisdictionThis Loan Agreement, dated as of June 8, 2021 (this “Agreement”), is among Celularity Inc., a Delaware corporation (the “Borrower”), and the lenders party hereto (collectively, the “Lenders” and each, a “Lender” and, together with the Borrower, the “Parties” and each, a “Party”).